| PERIOD ENDING | 27-Dec-08 | 30-Jun-08 | | Total Revenue | 93,052 | 138,668 | | Cost of Revenue | 27,488 | 39,779 | | | Gross Profit | 65,564 | 98,889 | | | Operating Expenses | | Research Development | 15,623 | 40,867 | | Selling General and Administrative | 54,453 | 74,674 | | Non Recurring |
-
| 5,856 | | Others | 5,380 | 7,115 | | | | Total Operating Expenses |
-
| 128,512 | | | | Operating Income or Loss | (9,892) | (29,623) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,600 | 14,681 | | Earnings Before Interest And Taxes | (8,292) | (14,942) | | Interest Expense | 6,003 |
-
| | Income Before Tax | (14,295) | (14,942) | | Income Tax Expense | (1,178) | 89,122 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (13,117) | (104,064) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (13,117) | (104,064) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($13,117) | ($104,064) |
|
0.29% Nasdaq 
Income Statement
